Medlarks Private Limited is a MedTech startup dedicated to developing medical innovations that enhance treatment outcomes and quality of life. With the aim to address the prevalent issue of Catheter Associated Urinary Tract Infection (CAUTI) in hospitalized patients, the company has created a revolutionary device called “UroVib”, designed to prevent this infection and ensure a safer hospital stay. The technology behind UroVib is the result of collaboration between the School of International Biodesign (SiB), a program involving AIIMS and IIT Delhi, with support from the Department of Biotechnology (DBT), Government of India. Founded in 2022, Medlarks Private Limited operates within the Manufacturing, Medical Devices, and Women's Health sectors and has yet to disclose its headquarters or any previous investment details. This innovative venture presents compelling opportunities for investors interested in the cutting-edge intersection of medicine and technology.
There is no investment information
No recent news or press coverage available for Medlarks Private Limited.